NCT03081455View on ClinicalTrials.gov

Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes

CompletedOBSERVATIONAL

Enrollment

145

Participants

Timeline

Start Date

February 13, 2017

Primary Completion Date

July 7, 2017

Study Completion Date

August 4, 2017

Conditions

Hereditary Cancer

Interventions

DIAGNOSTIC_TEST

Diagnostic Test

Genetic Diagnostic Testing

Trial Locations (2)

13203

Associates for Women's Medicine, Syracuse

06708

Westwood Women's Health, Waterbury

Sponsors

Collaborators (1)

Myriad Genetics, Inc.

All Listed Sponsors

collaborator

Myriad Genetics, Inc.

INDUSTRY

lead

Myriad Genetic Laboratories, Inc.

INDUSTRY